SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-152379
Filing Date
2021-05-06
Accepted
2021-05-06 06:06:02
Documents
14
Period of Report
2021-05-03
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d403517d8k.htm   iXBRL 8-K 25562
2 EX-3.1 d403517dex31.htm EX-3.1 3780
3 EX-3.2 d403517dex32.htm EX-3.2 165760
  Complete submission text file 0001193125-21-152379.txt   361694

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA grts-20210503.xsd EX-101.SCH 3096
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE grts-20210503_lab.xml EX-101.LAB 19638
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grts-20210503_pre.xml EX-101.PRE 12329
7 EXTRACTED XBRL INSTANCE DOCUMENT d403517d8k_htm.xml XML 3669
Mailing Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608
Business Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608 (510) 871-6100
Gritstone bio, Inc. (Filer) CIK: 0001656634 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38663 | Film No.: 21895566
SIC: 2836 Biological Products, (No Diagnostic Substances)